Platform Technology Partners’s Matinas BioPharma MTNB Stock Holding History

Platform Technology Partners’s Portfolio MTNB Stock Details MTNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-3,125	Closed	-$24.7K	–	232
2024 Q2	$24.7K	Buy	+3,125	New	+$28.3K	0.01%	222
2023 Q4	$33K	Sell	3,125 -123	-4%	-$1.39K	0.01%	199
2023 Q3	$21.1K	Hold	3,248	–	–	0.01%	196
2023 Q2	$64.1K	Hold	3,248	–	–	0.03%	193
2023 Q1	$76.3K	Hold	3,248	–	–	0.04%	189
2022 Q4	$81.2K	Hold	3,248	–	–	0.04%	186
2022 Q3	$103K	Buy	3,248 +400	+14%	+$15.7K	0.06%	171
2022 Q2	$113K	Hold	2,848	–	–	0.06%	177
2022 Q1	$115K	Sell	2,848 -375	-12%	-$13.8K	0.06%	191
2021 Q4	$163K	Sell	3,223 -80	-2%	-$4.28K	0.07%	195
2021 Q3	$215K	Sell	3,303 -520	-14%	-$22.4K	0.1%	192
2021 Q2	$148K	Buy	+3,823	New	+$164K	0.06%	233
2020 Q4	$216K	Sell	3,173 -210	-6%	-$9.72K	0.11%	192
2020 Q3	$130K	Buy	3,383 +483	+17%	+$19.2K	0.08%	183
2020 Q2	$112K	Buy	2,900 +900	+45%	+$34.5K	0.08%	181
2020 Q1	$60K	Hold	2,000	–	–	0.05%	163
2019 Q4	$227K	Buy	+2,000	New	+$116K	0.17%	150

Other funds holding MTNB

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

HCM

Highbridge Capital Management New York $4.11B AUM 26.03% 1-Year Est. Return

SIG

Sargent Investment Group Bethesda, Maryland $832M AUM 24.89% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Squarepoint New York $90.5B AUM 33.95% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.25B AUM 41.83% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return

Platform Technology Partners's MTNB Position: Q3 2024 in Review

Platform Technology Partners sold out of Matinas BioPharma (MTNB) in Q3 2024, closing a stake of 3,125 shares — an estimated $24.7K sold.

Platform Technology Partners first reported a position in MTNB in Q4 2019 and held it in 17 quarters. The position peaked at $227K in Q4 2019. 18 funds tracked by Wall St. Rank hold MTNB as of Q3 2024.

Platform Technology Partners reported no remaining Matinas BioPharma position as of Q3 2024 after selling out during the quarter.
Platform Technology Partners sold 3,125 Matinas BioPharma shares in Q3 2024, an estimated $24.7K.
Platform Technology Partners first reported a position in Matinas BioPharma in Q4 2019 and held it in 17 quarters.
Platform Technology Partners's Matinas BioPharma position peaked at $227K in Q4 2019.
18 funds tracked by Wall St. Rank held Matinas BioPharma as of Q3 2024.

Based on Platform Technology Partners's 13F filing for Q3 2024, filed 4 Nov 2024.